Author Affiliations
- Coralie Hoareau-Aveilla1,2,3,*,
- Cathy Quelen1,2,3,*,
- Annabelle Congras1,2,3,§,
- Nina Caillet1,2,3,§,
- Delphine Labourdette4,
- Christine Dozier1,2,3,
- Pierre Brousset1,2,3,5,6,7,§,
- Laurence Lamant1,2,3,5,6,7,§ and
- Fabienne Meggetto1,2,3,5,6,7,§⇑
- 1Inserm, UMR1037 CRCT, F-31000 Toulouse, France
- 2Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France
- 3CNRS, ERL5294 CRCT, F-31000 Toulouse, France
- 4Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
- 5Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France
- 6Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France
- 7European Research Initiative on ALK-Related Malignancies, Cambridge, UK
- Correspondence:
fabienne.meggetto{at}inserm.fr
Article Information
vol. 104 no. 2 347-359
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 9, 2018
- Accepted September 21, 2018
Article Versions
- previous version (September 27, 2018 - 03:57).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
Author Information
- Coralie Hoareau-Aveilla1,2,3,*,
- Cathy Quelen1,2,3,*,
- Annabelle Congras1,2,3,§,
- Nina Caillet1,2,3,§,
- Delphine Labourdette4,
- Christine Dozier1,2,3,
- Pierre Brousset1,2,3,5,6,7,§,
- Laurence Lamant1,2,3,5,6,7,§ and
- Fabienne Meggetto1,2,3,5,6,7,§⇑
- 1Inserm, UMR1037 CRCT, F-31000 Toulouse, France
- 2Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France
- 3CNRS, ERL5294 CRCT, F-31000 Toulouse, France
- 4Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
- 5Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France
- 6Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France
- 7European Research Initiative on ALK-Related Malignancies, Cambridge, UK
- Correspondence:
fabienne.meggetto{at}inserm.fr